Coverage and Support to Help Patients Start and Stay on STELARA®

As of January 2017, STELARA® is available on approximately 70% of commercial plans requiring no biologic step edits* with open access through several national plans and pharmacy benefit managers (PBMs).

*Requiring no step edits indicates a drug will be given first-line biologic access and will not require stepping through other biologic therapies.

Including UnitedHealthcare®, UHC West®, OptumRx®, Aetna® (pharmacy benefit only), Anthem®, Express Scripts®, and Humana® (medical benefit only); as of September 8, 2016.

Step edits required by biologic-naïve patients only.


Janssen CarePath


Access support

To help you navigate payer processes


Affordability support

To help your patients start and stay on treatment you prescribe


Treatment support

To help your patients get informed and stay on prescribed treatment



Prescribe STELARA®

Complete the Prescription Enrollment Form and fax it to 855-224-5072

Download Form Complete Form Online


Patient insurance benefit investigation is provided as a service by The Lash Group, Inc., under contract for Janssen Biotech, Inc. In this regard, Janssen Biotech, Inc., and The Lash Group, Inc., assists healthcare professionals in the determination of whether treatment could be covered by the applicable third-party payer based on coverage guidelines provided by the payer and patient information provided by the healthcare provider under appropriate authorization following the provider’s exclusive determination of medical necessity.

Importantly, insurance verification is the ultimate responsibility of the provider. Third-party reimbursement is affected by many factors. Therefore, The Lash Group, Inc., and Janssen Biotech, Inc., make no representation or guarantee that full or partial insurance reimbursement or any other payment will be available. This information is provided as an information service only. While The Lash Group, Inc., tries to provide correct information, they and Janssen Biotech, Inc., make no representations or warranties, expressed or implied, as to the accuracy of the information. In no event shall The Lash Group, Inc., or Janssen Biotech, Inc., or its employees or agents be liable for any damages resulting from or relating to the services. All providers and other users of this information agree that they accept responsibility for the use of this service.

Janssen Biotech, Inc., assumes no responsibility for, and does not guarantee the quality, scope, or availability of the services including but not limited to reimbursement support services, patient education, and other support services. Each provider, not Janssen Biotech, Inc., is responsible for the services they provide. These support services have no independent value to providers apart from the product and are included within the cost of the product.

Janssen CarePath Savings Program

Eligible commercial patients pay JUST $5 for each dose

Your patients get savings off their deductible, co-pay, and co-insurance medication costs for STELARA®

  • $20,000 maximum program benefit per calendar year

    – For medication cost only; not available to patients who use any state or federal government-subsidized healthcare program to cover a portion of medication costs, such as Medicare, Medicaid, TRICARE®, Department of Defense (DoD), or Veterans Administration (VA); see full eligibility requirements at TRICARE® is a registered trademark of the DoD, DHA.

  • Program does not cover cost of administering treatment
  • No income requirement

Enrollment and activation at or call 877-CarePath (877-227-3728).

Janssen Biotech, Inc., the maker of STELARA®, is not liable for unintended or unauthorized use of the STELARA® MasterCard® if it is lost or stolen. The Janssen CarePath Savings Program for STELARA® Prepaid MasterCard is issued by MetaBank®, Member FDIC, pursuant to license by MasterCard International Incorporated. MasterCard is a registered trademark of MasterCard International Incorporated. Janssen CarePath Savings Program is not a MetaBank product and is not endorsed by them.